Evidence map›Paper›PMID 12600225›Full record

ReviewDrugs2003

Diagnosis and treatment of patients with pouchitis.

Bo Shen

2 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Drugs, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00583076 phase2completednot on this mapstarted 2007, after this paper: background citation

A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Active Pouchitis

TypeinterventionalSponsorOcera TherapeuticsRan2007 to 2008Enrolled19ConditionsPouchitisArmsAST-120
NCT03538366 nacompletednot on this mapstarted 2018, after this paper: background citation

Fecal Microbiota Transplantation for the Treatment of Chronic Pouchitis

TypeinterventionalSponsorAalborg University HospitalRan2018 to 2019Enrolled10ConditionsUlcerative Colitis, PouchitisArmsDonor FMT
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Efficiency of Diagnostic Testing forAntibiotics (Basel, Switzerland) · 2021
    Review
  5. Medical treatment of pouchitis: a guide for the clinician.Therapeutic advances in gastroenterology · 2021
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Pouchitis: a practical guide.Frontline gastroenterology · 2013
    Review
  11. Chronic use of PPI and H2 antagonists decreases the risk of pouchitis after IPAA for ulcerative colitis.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2013
    Article
  12. Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.Nature reviews. Gastroenterology & hepatology · 2012
    Review
  13. Evaluation of upper and lower gastrointestinal histology in patients with ileal pouches.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2012
    Article
  14. Surgical prophylaxis of pouchitis in ulcerative colitis.Digestive diseases and sciences · 2011
    Review
  15. Diagnosis and management of postoperative ileal pouch disorders.Clinics in colon and rectal surgery · 2010
    Article
  16. Article
  17. Article
  18. Diagnosis and treatment of pouchitis.Gastroenterology & hepatology · 2008
    Article
  19. Pouchitis.World journal of gastroenterology · 2007
    Review
  20. [Ileo pouch-anal anastomosis].Der Internist · 2007
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Bo ShenDepartment of Gastroenterology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA. shenb@ccf.org
Cleveland Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pouchitis is the most common long-term complication of ileal pouch-anal anastomosis in patients with underlying ulcerative colitis. Clinical symptoms of pouchitis are not specific, and they can be caused by other conditions such as rectal cuff inflammation and irritable pouch syndrome. Therefore, to make an accurate diagnosis, endoscopic evaluation together with symptom assessment is necessary. Among five available treat-first and test-first strategies, the initial approach with pouch endoscopy without histology was the most cost-effective strategy for the diagnosis of pouchitis. On the basis of clinical course, pouchitis can be classified into acute, relapsing and chronic forms. Pouchitis can also be classified into three categories based on the response to antibacterial therapy: antibacterial-responsive; antibacterial-dependent; and antibacterial-resistant. Metronidazole and ciprofloxacin are both effective in treating acute pouchitis. Although antibacterial therapy can induce and maintain remission, probiotics such as VSL#3 can also be used as to maintain clinical remission and prevent relapse in patients with relapsing or chronic pouchitis. For patients with chronic pouchitis that is resistant to antibacterials, therapy with anti-inflammatory agents and immunomodulators is often required.

Indexed as

Acute DiseaseAdjuvants, ImmunologicAnti-Infective AgentsAnti-Inflammatory AgentsChronic DiseaseDrug Administration ScheduleEndoscopy, GastrointestinalHumansImmunosuppressive AgentsPouchitisRandomized Controlled Trials as TopicAdjuvants, ImmunologicAnti-Infective AgentsAnti-Inflammatory AgentsImmunosuppressive Agents

Identifiers

PMID12600225
OpenAlexW1973201714

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.